🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

PROMPT *all* the things! #HLTH2024

I'm 100% convinced that the bulk of MAGA grievances are that they just genuinely do not know how anything works, so they get mad at the people who do.

KAMALA WITH THE HAIL MARY??!

🤌🤌🤌🇮🇹🍝 Anthony Volpe 👑🗽

Obama in 2028 when Trump repeals the 22nd ammendment

Again, people don’t realize how bad it’s going to be for an anti-vaxxer conspiracy theorist to be in charge of our nation’s public health.

Stop by the Boehringer Ingelheim booth at ASHP Midyear in NOLA to meet my hologram! Yes…an actual 3D hologram 😂

drew lock would be a good bridge quarterback for us next year in the sense that if hes our quarterback next year i will jump off a bridge

Mavacamten is covered by 25% Medicare plans, but 94% plans mandate prior auths and most have high out-of-pocket costs Kannu Bansal Saurabh S Dani, MD, MSc Lahey Cardiology @YaleHFdoc Ahmad Masri Ralph J. Riello III, PharmD, BCPS #AHAJournals ahajrnls.org/4jBNofo

RFK Jr: Screams about dyes in food which ARE regulated for safety and Screams about vaccine ingredients which ARE tested and regulated for safety While consuming a synthetic dye, methylene blue, that is NOT regulated OR tested for safety & encouraging others to do so too. 1/

lower is better—but lower *for longer* is best 💊🫀

Tariq Ahmad MD MPH Nihar Desai MD MPH Ralph J. Riello III, PharmD, BCPS and colleagues found that only 25% of Medicare Part D plans cover mavacamten, and almost all plans require prior authorizations and high cost-sharing levels. #financialtoxicity #HCM Yale Cardiology pubmed.ncbi.nlm.nih.gov/39817331/

The Interventional Cardiologist arriving for STEMI call.

As a Giants fan, we gotta take some credit for this Eagles dominance. You’re not here without the incompetence of OUR front office. #wemissyousaquon

Round One ✅ KeyBank | #MenOfMarch

Join us for another PGY2 CE Spotlight! This time we are joined by Yeganeh Haghi, Yeganeh R. Haghi from BIDMC Pharmacy Residency Programs The topic this week is on the role of GLP-1 receptor agonists in cardiovascular-kidney-metabolic health! #CardioCE

very rare to see a head-to-head RCT of two market leading blockbusters, $LLY & $NOVO, specially with 6+ years still left on either GLP1RA’s patent 👏 bold science; bad trade 😂📉

Happy Monday (a day early!) a new MJH Life Sciences® Pharmacy Times Tell-Tale Heart Podcast. Listen as Ralph J. Riello III, PharmD, BCPS and I discuss how pharmacist can implement the PROMPT trials in your system! Listen here or where you get your podcast: audioboom.com/posts/8729124-…

You don’t know what you have until it’s gone, Storrs edition:

elon’s ketamine plug needs to put in work today, we can have him admit election interference and put this app up for sale by tonight if bro locks in